Mass screening for colorectal cancer: What stage are we up to?;Le depistage de masse du cancer colorectal: Ou en est-on?

Bulletin du Cancer

Volumn 83, Issue 9, 1996, Pages 746-749

  Tazi, M A ^a   Faivre, J ^a   Benhamiche, A M ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

colorectal cancer; faecal occult blood testing; mass screening

Indexed keywords

CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; CONFERENCE PAPER; FECES; HUMAN; OCCULT BLOOD; AGED; CASE CONTROL STUDY; CLINICAL TRIAL; COLON TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FRANCE; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR; REVIEW; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; EVALUATION STUDIES; FRANCE; HUMANS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S ROLE; RECTAL NEOPLASMS; RISK FACTORS;

EID: 0029776840     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Arveux P, Durand G, Milan C et al. Views of a general population on mass screening for colorectal cancer: the Burgundy study. Prev Med 1992;21:574-81
2. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of cancer patients in Europe. The Eurocare study. IARC Sci Publ 19951:132
3. ®. Rev Med Ass Mal 1988;4:13-8
4. Durand G, Arveux P, Milan C, Quelier C, Bedenne L, Faivre J. Vécu d'une campagne de dépistage de masse des cancers colorectaux par les médecins généralistes. Cah Sociol Démogr Méd 1992;22:197-206
5. Eddy DM. Secondary prevention of cancer: an overview. Bull WHO 1986;64:421-9
6. Faivre J, Arveux P, Milan C, Durand G, Lamour J, Bedenne LP. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev 1991;1:49-55
7. Hardcastle JD, Thomas WH, Chamberlain J et al. Randomised controlled trial a faecal occult blood screening for colorectal cancer. Results for first 17349 subjects. Lancet 1989; i:1160-4
8. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult 17 blood testing in 27 700 subjects. Cancer 1988;62:645-51
9. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989;24:599-606
10. Lallemand RC, Vakil PA, Pearson P, Box V. Screening for asymptomatic bowel cancer in general practice. Br Med J 1984;288:31-3
11. Lang CA, Ransohoff DF. Faecal occult blood tests: choice, usage and clinical applications. JAMA 1992;271:1011-3
12. Launoy G, Grosclaude P, Pienkowski P et al. Les cancers digestifs en France. Comparaison de l'incidence dans sept départements et estimation de l'incidence pour la France entière. Gastroenterol Clin Biol 1992;16:633-8
13. Launoy G, Herbert C, Vallee JP et al. Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165 000 personnes dans le Calvados. Gastroenterol Clin Biol (sous presse)
14. Lazovich D, Weiss NS, Stevens NG, White E, McKnight B, Wagner EH. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screening 1955;2: 84-9
15. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71
16. Moutet JP, Michiels C, Milan C, Hillon P, Faivre J. La stratégie actuelle de détection des polypes peut-elle faire baisser l'incidence du cancer de l'intestin? In: Ducimetière P, Montaville B, Schaffer P, Spira N, éds. Recherche et politique de santé. L'apport des registres de morbidité. Paris : Inserm, 1992:187-90
17. Nichols S, Koch E, Lallemand RC et al. Randomised trial of compliance with screening for colorectal cancer. Br Med J 1986;293:107-10
18. Saito H, Soma Y, Koeda J et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995;61:465-9
19. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. Ann Intern Med 1993;104:1661-8
20. Warhendorf J, Robra BP, Wiebelt H, Oberhausen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control study in Saarland, Germany. Eur J Cancer Prev 1993; 2:221-7
21. Young GP, St John DJB. Faecal occult blood tests: choice, usage and clinical applications. Clin Biochem Rev 1992;13: 161-7